PURPOSE: To investigate the clinical and molecular ge-netic features of childhood-onset Leber hereditary optic neuropathy (LHON) to gain a better understanding of the factors influencing the visual outcome in this atypical form of the disease.center dot DESIGN: Retrospective cohort study.center dot METHODS: We retrospectively included 2 cohorts of pa-tients with LHON with onset of visual loss before the age of 12 years from Italy and the United Kingdom. Ophthal-mologic evaluation, including best-corrected visual acu-ity, orthoptic evaluation, slit-lamp biomicroscopy, visual field testing, and optical coherence tomography, was con-sidered. Patients were classified based on both the age of onset and the pattern of visual loss.center dot RESULTS: A total of 68 patients were stratified based on the age of onset of visual loss: group 1 ( < 3 years): 14 patients (20.6%); group 2 ( >3 to < 9 years): 27 patients (39.7%); and group 3 ( >9 to <12 years): 27 patients (39.7%). Patients in group 2 achieved a better visual out-come than those in group 3. Patients in groups 1 and 2 had better mean deviation on visual field testing than those in group 3. The mean ganglion cell layer thickness on optical coherence tomography in group 2 was higher than those in groups 1 and 3. Patients were also catego-rized based on the pattern of visual loss as follows: Suba-cute Bilateral: 54 patients (66.7%); Insidious Bilateral: 14 patients (17.3%); Unilateral: 9 patients (11.1%); and Subclinical Bilateral: 4 patients (4.9%).center dot CONCLUSIONS: Children who lose vision from LHON before the age of 9 years have a better visual prognosis than those who become affected in later years, likely rep-resenting a "form frustre" of the disease. (Am J Oph-thalmol 2023;249: 99-107. (c) 2022 Elsevier Inc. All rights reserved.)

Childhood-Onset Leber Hereditary Optic Neuropathy-Clinical and Prognostic Insights / P. Barboni, C. La Morgia, M.L. Cascavilla, E.H. Hong, M. Battista, A. Majander, L. Caporali, V. Starace, G. Amore, A.D. Renzo, M. Carbonelli, P. Nucci, N. Jurkute, B.S. Chen, R. Panebianco, A.M. De Negri, F. Sadun, V. Parisi, F. Bandello, A.A. Sadun, V. Carelli, P. Yu-Wai-Man. - In: AMERICAN JOURNAL OF OPHTHALMOLOGY. - ISSN 0002-9394. - 249:(2023 May), pp. 99-107. [10.1016/j.ajo.2022.12.014]

Childhood-Onset Leber Hereditary Optic Neuropathy-Clinical and Prognostic Insights

P. Nucci;
2023

Abstract

PURPOSE: To investigate the clinical and molecular ge-netic features of childhood-onset Leber hereditary optic neuropathy (LHON) to gain a better understanding of the factors influencing the visual outcome in this atypical form of the disease.center dot DESIGN: Retrospective cohort study.center dot METHODS: We retrospectively included 2 cohorts of pa-tients with LHON with onset of visual loss before the age of 12 years from Italy and the United Kingdom. Ophthal-mologic evaluation, including best-corrected visual acu-ity, orthoptic evaluation, slit-lamp biomicroscopy, visual field testing, and optical coherence tomography, was con-sidered. Patients were classified based on both the age of onset and the pattern of visual loss.center dot RESULTS: A total of 68 patients were stratified based on the age of onset of visual loss: group 1 ( < 3 years): 14 patients (20.6%); group 2 ( >3 to < 9 years): 27 patients (39.7%); and group 3 ( >9 to <12 years): 27 patients (39.7%). Patients in group 2 achieved a better visual out-come than those in group 3. Patients in groups 1 and 2 had better mean deviation on visual field testing than those in group 3. The mean ganglion cell layer thickness on optical coherence tomography in group 2 was higher than those in groups 1 and 3. Patients were also catego-rized based on the pattern of visual loss as follows: Suba-cute Bilateral: 54 patients (66.7%); Insidious Bilateral: 14 patients (17.3%); Unilateral: 9 patients (11.1%); and Subclinical Bilateral: 4 patients (4.9%).center dot CONCLUSIONS: Children who lose vision from LHON before the age of 9 years have a better visual prognosis than those who become affected in later years, likely rep-resenting a "form frustre" of the disease. (Am J Oph-thalmol 2023;249: 99-107. (c) 2022 Elsevier Inc. All rights reserved.)
Settore MED/30 - Malattie Apparato Visivo
mag-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0002939422005013-main.pdf

accesso riservato

Descrizione: Original Article
Tipologia: Publisher's version/PDF
Dimensione 691.21 kB
Formato Adobe PDF
691.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/997060
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 2
social impact